您是这款应用的开发者吗？验证所有权以管理此应用条目。
The Center for Drug Evaluation and Research (CDER) assesses bioequivalence (BE) in generic drug applications primarily through a combination of regulatory requirements, scientific guidelines, and statistical criteria. The process ensures that a generic drug performs in the same manner as its reference listed drug (RLD).
免责声明：WebCatalog 与 Rhizome 不存在任何隶属、关联、授权或认可关系，也未以任何方式与其建立官方联系。所有产品名称、徽标和品牌均为其各自所有者的财产。
